Signal Transduction

Signal Transduction encompasses cellular communication pathways by which cells detect external signals through receptors and convert them into specific intracellular responses through cascading molecular events involving second messengers, protein phosphorylation, and transcriptional changes. These sophisticated relay systems enable cells to respond appropriately to hormones, growth factors, neurotransmitters, or environmental cues, with dysregulation contributing to diseases including cancer, diabetes, and autoimmune disorders.

The pharmaceutical industry extensively targets signal transduction pathways throughout drug discovery and development. Kinase inhibitors represent a major therapeutic class, blocking phosphorylation cascades in cancer and inflammatory diseases. Receptor antagonists prevent signal initiation, whilst agonists activate pathways therapeutically. Pathway analysis reveals disease mechanisms, identifies therapeutic targets, and discovers biomarkers predicting treatment responses. Resistance mechanisms often involve pathway bypass or reactivation, informing combination therapy strategies. Pharmacodynamic biomarkers measure pathway activity, confirming target engagement and optimal dosing. Personalised medicine approaches select patients based on pathway activation status. As understanding deepens through proteomics, phosphoproteomics, and systems approaches, and technologies advance enabling dynamic pathway monitoring, signal transduction research continues revealing therapeutic opportunities and resistance mechanisms through pathway-informed precision approaches.